Clinical Trials Directory

Trials / Terminated

TerminatedNCT02398578

Cystoscopic Ablation Via RF Energy Clinical Trial

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Amphora Medical, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Phase I/II study to assess the safety and performance of the Amphora OAB system for treatment of urgency and frequency with or without urge incontinence caused by an overactive bladder.

Detailed description

The study will enroll subjects with symptomatic idiopathic overactive bladder (OAB).

Conditions

Interventions

TypeNameDescription
DEVICEAmphora OAB DeviceCystoscopic procedure to treat OAB

Timeline

Start date
2015-02-01
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2015-03-25
Last updated
2019-05-07

Locations

4 sites across 2 countries: Belgium, Canada

Source: ClinicalTrials.gov record NCT02398578. Inclusion in this directory is not an endorsement.

Cystoscopic Ablation Via RF Energy Clinical Trial (NCT02398578) · Clinical Trials Directory